Intense Pulsed Light Therapy in Meibomian Gland Dysfunction

NCT04904874 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-05-27

No results posted yet for this study

Summary

to evaluate the effect of intense pulsed light on resistant patients with Meibomian gland dysfunction

Conditions

  • Meibomian Gland Dysfunction

Interventions

DEVICE

intense pulsed light

treatment with 3 sessions of intense pulsed light, the second one after 2 weeks, the third one after 6 weeks

Sponsors & Collaborators

  • Dar Al Shifa Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-07-30
Completion
2021-07-30

Countries

  • Kuwait

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904874 on ClinicalTrials.gov